S 2067
115th Congress
Senate
Prostate Cancer Misdiagnosis Elimination Act of 2017
Official title: A bill to amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of certain DNA Specimen Provenance Assay clinical diagnostic laboratory tests.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 2, 2017
Read twice and referred to the Committee on Finance.
Nov 2, 2017
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Read twice and referred to the Committee on Finance.
Plain-English summary
Prostate Cancer Misdiagnosis Elimination Act of 2017
This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 2067: Prostate Cancer Misdiagnosis Elimination Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-2067/
"S. 2067: Prostate Cancer Misdiagnosis Elimination Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2067/.
S. 2067, 115th Cong. (2026), https://openamerica.io/bill/115-S-2067/.
[S. 2067: Prostate Cancer Misdiagnosis Elimination Act of 2017](https://openamerica.io/bill/115-S-2067/)